Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has entered a key licensing agreement with Telesis Bio Inc. to integrate the ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Life is thought to have begun when RNA began replicating itself, and researchers have got close to achieving this in the lab ...

Lipid membranes, which form the outer layer of cells, can be engineered to influence cellular functions. For example, ...

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.

The publication introduces a genetic identification system that enables plasmids to carry embedded documentation, improving ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

The commission’s efforts culminated in the passage of the Cambridge Recombinant DNA Technology Ordinance by the city council 1977. The ordinance was critical in creating a stable, predictable ...